Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0336 Transporter Info | ||||
Gene Name | SLC38A9 | ||||
Transporter Name | Sodium-coupled neutral amino acid transporter 9 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg04401436) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 3.15E-08; Z-score: -1.37E+00 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.99E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg05146599) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.86E+00 | Statistic Test | p-value: 4.49E-08; Z-score: -2.11E+00 | ||
Methylation in Case |
1.31E-01 (Median) | Methylation in Control | 2.43E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg13598790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 5.80E-07; Z-score: 1.11E+00 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 7.99E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg18034294) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.48E+00 | Statistic Test | p-value: 2.21E-06; Z-score: -1.28E+00 | ||
Methylation in Case |
5.29E-01 (Median) | Methylation in Control | 7.86E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg05462905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.48E-03; Z-score: -6.64E-01 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.87E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg07042489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.30E-03; Z-score: -7.56E-01 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 9.00E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 3.73E-03; Z-score: -5.05E-01 | ||
Methylation in Case |
7.92E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC38A9 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg13589588) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.72E-02; Z-score: 3.98E-01 | ||
Methylation in Case |
8.99E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
11 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg05146599) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 1.47E-04; Z-score: -5.62E+00 | ||
Methylation in Case |
7.38E-01 (Median) | Methylation in Control | 8.21E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg13598790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 1.75E-02; Z-score: -1.07E+00 | ||
Methylation in Case |
3.81E-02 (Median) | Methylation in Control | 4.36E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg18034294) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.35E-02; Z-score: -1.23E+00 | ||
Methylation in Case |
8.69E-01 (Median) | Methylation in Control | 8.91E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg11493924) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 5.09E-04; Z-score: -2.71E+00 | ||
Methylation in Case |
5.86E-02 (Median) | Methylation in Control | 7.24E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg11466815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 3.93E-02; Z-score: -1.09E+00 | ||
Methylation in Case |
1.83E-02 (Median) | Methylation in Control | 2.21E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg10968375) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 2.42E-02; Z-score: -1.20E+00 | ||
Methylation in Case |
2.01E-02 (Median) | Methylation in Control | 2.89E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
Body (cg07042489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.45E-03; Z-score: -3.55E+00 | ||
Methylation in Case |
8.53E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
Body (cg05462905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.27E-03; Z-score: -2.88E+00 | ||
Methylation in Case |
6.73E-01 (Median) | Methylation in Control | 7.50E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
Body (cg24749564) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 2.29E-03; Z-score: 2.20E+00 | ||
Methylation in Case |
8.16E-01 (Median) | Methylation in Control | 7.80E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
Body (cg27622900) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 7.90E-03; Z-score: -1.89E+00 | ||
Methylation in Case |
7.82E-01 (Median) | Methylation in Control | 8.30E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC38A9 in bladder cancer | [ 2 ] | |||
Location |
Body (cg26540004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.11E+00 | Statistic Test | p-value: 2.27E-02; Z-score: 9.31E-01 | ||
Methylation in Case |
4.28E-01 (Median) | Methylation in Control | 3.84E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg05146599) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 8.04E-05; Z-score: 1.55E+00 | ||
Methylation in Case |
8.30E-01 (Median) | Methylation in Control | 7.76E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg18034294) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.23E-03; Z-score: -4.28E-01 | ||
Methylation in Case |
8.81E-01 (Median) | Methylation in Control | 8.90E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg13598790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 4.07E-02; Z-score: -4.33E-01 | ||
Methylation in Case |
2.77E-02 (Median) | Methylation in Control | 3.10E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg11493924) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 8.90E-03; Z-score: -3.30E-01 | ||
Methylation in Case |
5.87E-02 (Median) | Methylation in Control | 6.68E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
TSS1500 (cg09277365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 4.36E-02; Z-score: -5.28E-01 | ||
Methylation in Case |
4.80E-02 (Median) | Methylation in Control | 5.58E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg10968375) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 3.13E-02; Z-score: -5.84E-01 | ||
Methylation in Case |
9.94E-03 (Median) | Methylation in Control | 1.40E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
TSS200 (cg12824106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.29E+00 | Statistic Test | p-value: 3.20E-02; Z-score: -3.71E-01 | ||
Methylation in Case |
5.80E-03 (Median) | Methylation in Control | 7.47E-03 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.78E+00 | Statistic Test | p-value: 1.47E-18; Z-score: 3.24E+00 | ||
Methylation in Case |
4.35E-01 (Median) | Methylation in Control | 2.44E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
Body (cg07042489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.60E-04; Z-score: -7.83E-01 | ||
Methylation in Case |
8.58E-01 (Median) | Methylation in Control | 8.76E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
Body (cg26540004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.58E-03; Z-score: 9.00E-01 | ||
Methylation in Case |
4.77E-01 (Median) | Methylation in Control | 4.12E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
Body (cg13589588) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 6.19E-03; Z-score: -6.61E-01 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 8.62E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
Body (cg27622900) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 8.53E-03; Z-score: -7.33E-01 | ||
Methylation in Case |
7.71E-01 (Median) | Methylation in Control | 7.97E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC38A9 in breast cancer | [ 3 ] | |||
Location |
Body (cg24749564) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 2.76E-02; Z-score: 4.40E-01 | ||
Methylation in Case |
7.99E-01 (Median) | Methylation in Control | 7.79E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg04401436) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 4.68E-02; Z-score: 3.05E-01 | ||
Methylation in Case |
2.71E-02 (Median) | Methylation in Control | 2.54E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg11466815) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.05E+00 | Statistic Test | p-value: 9.07E-03; Z-score: 5.38E-01 | ||
Methylation in Case |
2.52E-02 (Median) | Methylation in Control | 2.40E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg11283154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 8.79E-03; Z-score: 6.50E-01 | ||
Methylation in Case |
2.36E-02 (Median) | Methylation in Control | 2.23E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg07397574) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.53E-02; Z-score: 2.82E-01 | ||
Methylation in Case |
1.72E-02 (Median) | Methylation in Control | 1.67E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg12824106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 2.68E-02; Z-score: 1.93E-01 | ||
Methylation in Case |
1.09E-02 (Median) | Methylation in Control | 1.07E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg09554558) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 4.08E-02; Z-score: 3.25E-01 | ||
Methylation in Case |
1.36E-02 (Median) | Methylation in Control | 1.30E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS200 (cg10968375) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 4.09E-02; Z-score: 5.38E-01 | ||
Methylation in Case |
1.32E-02 (Median) | Methylation in Control | 1.23E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg13598790) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 2.64E-03; Z-score: 6.53E-01 | ||
Methylation in Case |
2.01E-02 (Median) | Methylation in Control | 1.77E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in colorectal cancer | [ 5 ] | |||
Location |
TSS200 (cg10968375) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 2.45E-03; Z-score: 5.68E-01 | ||
Methylation in Case |
1.10E-02 (Median) | Methylation in Control | 9.34E-03 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in colorectal cancer | [ 5 ] | |||
Location |
TSS200 (cg09200496) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 3.94E-02; Z-score: -5.35E-01 | ||
Methylation in Case |
1.07E-01 (Median) | Methylation in Control | 1.17E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg27622900) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 4.29E-06; Z-score: -1.59E+00 | ||
Methylation in Case |
8.49E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.21E+00 | Statistic Test | p-value: 1.30E-05; Z-score: 1.36E+00 | ||
Methylation in Case |
6.52E-01 (Median) | Methylation in Control | 5.40E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in hepatocellular carcinoma | [ 6 ] | |||
Location |
5'UTR (cg05146599) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.00E-05; Z-score: -1.17E+00 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.51E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg26540004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.42E+00 | Statistic Test | p-value: 4.51E-08; Z-score: -1.36E+00 | ||
Methylation in Case |
2.59E-01 (Median) | Methylation in Control | 3.67E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg07042489) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 4.51E-08; Z-score: -1.35E+00 | ||
Methylation in Case |
7.51E-01 (Median) | Methylation in Control | 8.25E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.46E+00 | Statistic Test | p-value: 4.44E-07; Z-score: -1.44E+00 | ||
Methylation in Case |
2.37E-01 (Median) | Methylation in Control | 3.46E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in hepatocellular carcinoma | [ 6 ] | |||
Location |
Body (cg24749564) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 3.05E-03; Z-score: -4.70E-01 | ||
Methylation in Case |
8.04E-01 (Median) | Methylation in Control | 8.18E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
5'UTR (cg18034294) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 3.33E-02; Z-score: 7.86E-01 | ||
Methylation in Case |
9.52E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg11493924) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 1.34E-02; Z-score: 5.97E-01 | ||
Methylation in Case |
6.95E-02 (Median) | Methylation in Control | 6.16E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
TSS1500 (cg03329536) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 4.50E-02; Z-score: -3.25E-01 | ||
Methylation in Case |
5.34E-02 (Median) | Methylation in Control | 5.71E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
TSS200 (cg12824106) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.56E+00 | Statistic Test | p-value: 6.35E-03; Z-score: 7.59E-01 | ||
Methylation in Case |
7.25E-03 (Median) | Methylation in Control | 4.66E-03 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
TSS200 (cg11283154) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.48E+00 | Statistic Test | p-value: 3.35E-02; Z-score: 7.00E-01 | ||
Methylation in Case |
1.38E-02 (Median) | Methylation in Control | 9.37E-03 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
Body (cg26540004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 3.40E-06; Z-score: 1.94E+00 | ||
Methylation in Case |
7.94E-01 (Median) | Methylation in Control | 6.77E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
Body (cg27622900) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 1.08E-03; Z-score: 6.29E-01 | ||
Methylation in Case |
8.78E-01 (Median) | Methylation in Control | 8.69E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC38A9 in HIV infection | [ 7 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.24E-02; Z-score: 3.12E-01 | ||
Methylation in Case |
7.81E-01 (Median) | Methylation in Control | 7.67E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg21660392) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 1.11E-03; Z-score: -7.19E-01 | ||
Methylation in Case |
7.54E-01 (Median) | Methylation in Control | 7.83E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg08240652) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 1.67E-03; Z-score: 1.19E+00 | ||
Methylation in Case |
8.54E-01 (Median) | Methylation in Control | 7.45E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
5'UTR (cg12484332) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 4.95E-02; Z-score: -1.51E-01 | ||
Methylation in Case |
8.35E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg13161658) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.02E+00 | Statistic Test | p-value: 1.38E-05; Z-score: 1.43E+00 | ||
Methylation in Case |
3.23E-01 (Median) | Methylation in Control | 1.60E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg18584905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.26E+00 | Statistic Test | p-value: 1.89E-02; Z-score: -1.22E+00 | ||
Methylation in Case |
1.75E-01 (Median) | Methylation in Control | 2.21E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS1500 (cg03483626) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 2.09E-02; Z-score: 3.87E-01 | ||
Methylation in Case |
5.28E-01 (Median) | Methylation in Control | 5.06E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg22364668) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 4.71E-07; Z-score: 2.89E-01 | ||
Methylation in Case |
4.90E-02 (Median) | Methylation in Control | 4.57E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
TSS200 (cg17344085) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 1.33E-02; Z-score: -5.96E-01 | ||
Methylation in Case |
3.03E-02 (Median) | Methylation in Control | 3.37E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg03067613) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.19E+00 | Statistic Test | p-value: 8.57E-05; Z-score: 1.25E+00 | ||
Methylation in Case |
8.43E-01 (Median) | Methylation in Control | 7.11E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg15531450) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.14E+00 | Statistic Test | p-value: 3.16E-04; Z-score: 9.13E-01 | ||
Methylation in Case |
5.40E-01 (Median) | Methylation in Control | 4.75E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg02793733) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.77E-03; Z-score: -2.91E-01 | ||
Methylation in Case |
8.23E-01 (Median) | Methylation in Control | 8.35E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg19503341) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.09E-02; Z-score: 7.48E-01 | ||
Methylation in Case |
4.87E-01 (Median) | Methylation in Control | 4.56E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC38A9 in pancretic ductal adenocarcinoma | [ 8 ] | |||
Location |
Body (cg17461670) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.32E-02; Z-score: -3.69E-01 | ||
Methylation in Case |
8.63E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in systemic lupus erythematosus | [ 9 ] | |||
Location |
5'UTR (cg04401436) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.77E-02; Z-score: -7.40E-02 | ||
Methylation in Case |
9.11E-02 (Median) | Methylation in Control | 9.25E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in systemic lupus erythematosus | [ 9 ] | |||
Location |
TSS1500 (cg09277365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.38E-02; Z-score: -1.09E-01 | ||
Methylation in Case |
7.65E-02 (Median) | Methylation in Control | 7.87E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in systemic lupus erythematosus | [ 9 ] | |||
Location |
TSS200 (cg21173440) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 2.44E-02; Z-score: 5.96E-02 | ||
Methylation in Case |
1.86E-01 (Median) | Methylation in Control | 1.85E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in systemic lupus erythematosus | [ 9 ] | |||
Location |
Body (cg27622900) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 8.30E-03; Z-score: -2.90E-01 | ||
Methylation in Case |
8.57E-01 (Median) | Methylation in Control | 8.63E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in colon adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg11826452) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.30E-03; Z-score: -8.62E-01 | ||
Methylation in Case |
4.82E-01 (Median) | Methylation in Control | 5.09E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in colon adenocarcinoma | [ 10 ] | |||
Location |
TSS1500 (cg14282904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.46E+00 | Statistic Test | p-value: 1.36E-03; Z-score: 1.95E+00 | ||
Methylation in Case |
1.95E-01 (Median) | Methylation in Control | 7.92E-02 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in colon adenocarcinoma | [ 10 ] | |||
Location |
1stExon (cg16163981) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 3.89E-03; Z-score: 1.12E+00 | ||
Methylation in Case |
4.27E-01 (Median) | Methylation in Control | 3.78E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in colon adenocarcinoma | [ 10 ] | |||
Location |
3'UTR (cg03954999) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 2.26E-03; Z-score: -2.94E+00 | ||
Methylation in Case |
7.32E-01 (Median) | Methylation in Control | 8.38E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg11493924) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 7.53E-08; Z-score: -8.60E-01 | ||
Methylation in Case |
6.67E-02 (Median) | Methylation in Control | 8.28E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg09277365) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 2.12E-03; Z-score: -4.30E-01 | ||
Methylation in Case |
5.72E-02 (Median) | Methylation in Control | 6.31E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS1500 (cg03329536) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 2.74E-02; Z-score: -6.27E-01 | ||
Methylation in Case |
5.71E-02 (Median) | Methylation in Control | 6.24E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg10968375) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.11E+00 | Statistic Test | p-value: 3.43E-05; Z-score: -6.86E-01 | ||
Methylation in Case |
4.54E-02 (Median) | Methylation in Control | 5.02E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg09554558) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 3.51E-03; Z-score: -6.57E-01 | ||
Methylation in Case |
4.70E-02 (Median) | Methylation in Control | 5.10E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg26540004) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 1.78E-20; Z-score: -4.54E+00 | ||
Methylation in Case |
4.91E-01 (Median) | Methylation in Control | 7.34E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg24749564) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 2.06E-07; Z-score: -1.27E+00 | ||
Methylation in Case |
8.54E-01 (Median) | Methylation in Control | 8.82E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg05462905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.73E-03; Z-score: -5.69E-01 | ||
Methylation in Case |
8.80E-01 (Median) | Methylation in Control | 8.94E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC38A9 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 3.72E-02; Z-score: 3.77E-01 | ||
Methylation in Case |
4.02E-01 (Median) | Methylation in Control | 3.79E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in prostate cancer | [ 12 ] | |||
Location |
TSS200 (cg07920064) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.41E+00 | Statistic Test | p-value: 1.44E-03; Z-score: 3.39E+00 | ||
Methylation in Case |
4.96E-02 (Median) | Methylation in Control | 3.51E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC38A9 in prostate cancer | [ 12 ] | |||
Location |
Body (cg00502885) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.10E+00 | Statistic Test | p-value: 6.64E-04; Z-score: 5.27E+00 | ||
Methylation in Case |
9.14E-01 (Median) | Methylation in Control | 8.33E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC38A9 in prostate cancer | [ 12 ] | |||
Location |
Body (cg10062193) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.92E+00 | Statistic Test | p-value: 7.22E-04; Z-score: 5.15E+00 | ||
Methylation in Case |
7.96E-01 (Median) | Methylation in Control | 2.72E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC38A9 in prostate cancer | [ 12 ] | |||
Location |
3'UTR (cg03825810) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.64E+00 | Statistic Test | p-value: 5.06E-03; Z-score: -6.52E+00 | ||
Methylation in Case |
5.14E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in lung adenocarcinoma | [ 13 ] | |||
Location |
Body (cg07262873) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.32E+00 | Statistic Test | p-value: 1.10E-03; Z-score: 2.95E+00 | ||
Methylation in Case |
6.01E-01 (Median) | Methylation in Control | 4.56E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC38A9 in panic disorder | [ 14 ] | |||
Location |
Body (cg05462905) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 7.29E-03; Z-score: -2.28E-01 | ||
Methylation in Case |
5.42E-01 (Median) | Methylation in Control | 6.35E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
72 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-106a directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-106a | miRNA Mature ID | miR-106a-3p | ||
miRNA Sequence |
CUGCAAUGUAAGCACUUCUUAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 2 |
miR-122 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-122 | miRNA Mature ID | miR-122-5p | ||
miRNA Sequence |
UGGAGUGUGACAAUGGUGUUUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 3 |
miR-125a directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-125a | miRNA Mature ID | miR-125a-3p | ||
miRNA Sequence |
ACAGGUGAGGUUCUUGGGAGCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 4 |
miR-1264 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1264 | miRNA Mature ID | miR-1264 | ||
miRNA Sequence |
CAAGUCUUAUUUGAGCACCUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 5 |
miR-129 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-129 | miRNA Mature ID | miR-129-5p | ||
miRNA Sequence |
CUUUUUGCGGUCUGGGCUUGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 6 |
miR-1304 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1304 | miRNA Mature ID | miR-1304-3p | ||
miRNA Sequence |
UCUCACUGUAGCCUCGAACCCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 7 |
miR-130a directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-130a | miRNA Mature ID | miR-130a-3p | ||
miRNA Sequence |
CAGUGCAAUGUUAAAAGGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 8 |
miR-130b directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-130b | miRNA Mature ID | miR-130b-3p | ||
miRNA Sequence |
CAGUGCAAUGAUGAAAGGGCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 9 |
miR-145 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-145 | miRNA Mature ID | miR-145-3p | ||
miRNA Sequence |
GGAUUCCUGGAAAUACUGUUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 10 |
miR-183 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-183 | miRNA Mature ID | miR-183-5p | ||
miRNA Sequence |
UAUGGCACUGGUAGAAUUCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 11 |
miR-1911 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1911 | miRNA Mature ID | miR-1911-5p | ||
miRNA Sequence |
UGAGUACCGCCAUGUCUGUUGGG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 12 |
miR-1972 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-1972 | miRNA Mature ID | miR-1972 | ||
miRNA Sequence |
UCAGGCCAGGCACAGUGGCUCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 13 |
miR-1976 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-1976 | miRNA Mature ID | miR-1976 | ||
miRNA Sequence |
CCUCCUGCCCUCCUUGCUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 14 |
miR-2113 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-2113 | miRNA Mature ID | miR-2113 | ||
miRNA Sequence |
AUUUGUGCUUGGCUCUGUCAC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 15 |
miR-24-1 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-24-1 | miRNA Mature ID | miR-24-1-5p | ||
miRNA Sequence |
UGCCUACUGAGCUGAUAUCAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 16 |
miR-24-2 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-24-2 | miRNA Mature ID | miR-24-2-5p | ||
miRNA Sequence |
UGCCUACUGAGCUGAAACACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 17 |
miR-301a directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-301a | miRNA Mature ID | miR-301a-3p | ||
miRNA Sequence |
CAGUGCAAUAGUAUUGUCAAAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 18 |
miR-301b directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-301b | miRNA Mature ID | miR-301b-3p | ||
miRNA Sequence |
CAGUGCAAUGAUAUUGUCAAAGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 19 |
miR-3135b directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3135b | miRNA Mature ID | miR-3135b | ||
miRNA Sequence |
GGCUGGAGCGAGUGCAGUGGUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 20 |
miR-3194 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3194 | miRNA Mature ID | miR-3194-5p | ||
miRNA Sequence |
GGCCAGCCACCAGGAGGGCUG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 21 |
miR-330 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-330 | miRNA Mature ID | miR-330-3p | ||
miRNA Sequence |
GCAAAGCACACGGCCUGCAGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 22 |
miR-3652 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3652 | miRNA Mature ID | miR-3652 | ||
miRNA Sequence |
CGGCUGGAGGUGUGAGGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 23 |
miR-3654 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3654 | miRNA Mature ID | miR-3654 | ||
miRNA Sequence |
GACUGGACAAGCUGAGGAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 24 |
miR-3666 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3666 | miRNA Mature ID | miR-3666 | ||
miRNA Sequence |
CAGUGCAAGUGUAGAUGCCGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 25 |
miR-3675 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-3675 | miRNA Mature ID | miR-3675-3p | ||
miRNA Sequence |
CAUCUCUAAGGAACUCCCCCAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 26 |
miR-371a directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-371a | miRNA Mature ID | miR-371a-5p | ||
miRNA Sequence |
ACUCAAACUGUGGGGGCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 27 |
miR-371b directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-371b | miRNA Mature ID | miR-371b-5p | ||
miRNA Sequence |
ACUCAAAAGAUGGCGGCACUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 28 |
miR-372 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-372 | miRNA Mature ID | miR-372-5p | ||
miRNA Sequence |
CCUCAAAUGUGGAGCACUAUUCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 29 |
miR-373 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-373 | miRNA Mature ID | miR-373-5p | ||
miRNA Sequence |
ACUCAAAAUGGGGGCGCUUUCC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 30 |
miR-3934 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-3934 | miRNA Mature ID | miR-3934-5p | ||
miRNA Sequence |
UCAGGUGUGGAAACUGAGGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 31 |
miR-4295 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4295 | miRNA Mature ID | miR-4295 | ||
miRNA Sequence |
CAGUGCAAUGUUUUCCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 32 |
miR-4430 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4430 | miRNA Mature ID | miR-4430 | ||
miRNA Sequence |
AGGCUGGAGUGAGCGGAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 33 |
miR-4474 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4474 | miRNA Mature ID | miR-4474-5p | ||
miRNA Sequence |
UUAGUCUCAUGAUCAGACACA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 34 |
miR-4520 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4520 | miRNA Mature ID | miR-4520-3p | ||
miRNA Sequence |
UUGGACAGAAAACACGCAGGAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 35 |
miR-454 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-454 | miRNA Mature ID | miR-454-3p | ||
miRNA Sequence |
UAGUGCAAUAUUGCUUAUAGGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 36 |
miR-4638 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4638 | miRNA Mature ID | miR-4638-3p | ||
miRNA Sequence |
CCUGGACACCGCUCAGCCGGCCG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 37 |
miR-4659a directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4659a | miRNA Mature ID | miR-4659a-3p | ||
miRNA Sequence |
UUUCUUCUUAGACAUGGCAACG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 38 |
miR-4659b directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4659b | miRNA Mature ID | miR-4659b-3p | ||
miRNA Sequence |
UUUCUUCUUAGACAUGGCAGCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 39 |
miR-4661 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4661 | miRNA Mature ID | miR-4661-3p | ||
miRNA Sequence |
CAGGAUCCACAGAGCUAGUCCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 40 |
miR-4695 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4695 | miRNA Mature ID | miR-4695-3p | ||
miRNA Sequence |
UGAUCUCACCGCUGCCUCCUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 41 |
miR-4722 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4722 | miRNA Mature ID | miR-4722-3p | ||
miRNA Sequence |
ACCUGCCAGCACCUCCCUGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 42 |
miR-4755 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4755 | miRNA Mature ID | miR-4755-3p | ||
miRNA Sequence |
AGCCAGGCUCUGAAGGGAAAGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 43 |
miR-4772 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-4772 | miRNA Mature ID | miR-4772-3p | ||
miRNA Sequence |
CCUGCAACUUUGCCUGAUCAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 44 |
miR-4775 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4775 | miRNA Mature ID | miR-4775 | ||
miRNA Sequence |
UUAAUUUUUUGUUUCGGUCACU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 45 |
miR-4778 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-4778 | miRNA Mature ID | miR-4778-3p | ||
miRNA Sequence |
UCUUCUUCCUUUGCAGAGUUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 46 |
miR-488 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-488 | miRNA Mature ID | miR-488-5p | ||
miRNA Sequence |
CCCAGAUAAUGGCACUCUCAA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 47 |
miR-500a directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-500a | miRNA Mature ID | miR-500a-5p | ||
miRNA Sequence |
UAAUCCUUGCUACCUGGGUGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 48 |
miR-501 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-501 | miRNA Mature ID | miR-501-5p | ||
miRNA Sequence |
AAUCCUUUGUCCCUGGGUGAGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 49 |
miR-5010 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5010 | miRNA Mature ID | miR-5010-3p | ||
miRNA Sequence |
UUUUGUGUCUCCCAUUCCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 50 |
miR-504 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-504 | miRNA Mature ID | miR-504-3p | ||
miRNA Sequence |
GGGAGUGCAGGGCAGGGUUUC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 51 |
miR-5197 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-5197 | miRNA Mature ID | miR-5197-5p | ||
miRNA Sequence |
CAAUGGCACAAACUCAUUCUUGA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 52 |
miR-519d directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-519d | miRNA Mature ID | miR-519d-5p | ||
miRNA Sequence |
CCUCCAAAGGGAAGCGCUUUCUGUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 53 |
miR-548aa directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548aa | miRNA Mature ID | miR-548aa | ||
miRNA Sequence |
AAAAACCACAAUUACUUUUGCACCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 54 |
miR-548ap directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548ap | miRNA Mature ID | miR-548ap-3p | ||
miRNA Sequence |
AAAAACCACAAUUACUUUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 55 |
miR-548as directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548as | miRNA Mature ID | miR-548as-3p | ||
miRNA Sequence |
UAAAACCCACAAUUAUGUUUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 56 |
miR-548at directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548at | miRNA Mature ID | miR-548at-3p | ||
miRNA Sequence |
CAAAACCGCAGUAACUUUUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 57 |
miR-548ay directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548ay | miRNA Mature ID | miR-548ay-3p | ||
miRNA Sequence |
CAAAACCGCGAUUACUCUUGCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 58 |
miR-548t directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-548t | miRNA Mature ID | miR-548t-3p | ||
miRNA Sequence |
AAAAACCACAAUUACUUUUGCACCA | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 59 |
miR-551b directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-551b | miRNA Mature ID | miR-551b-5p | ||
miRNA Sequence |
GAAAUCAAGCGUGGGUGAGACC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 60 |
miR-564 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-564 | miRNA Mature ID | miR-564 | ||
miRNA Sequence |
AGGCACGGUGUCAGCAGGC | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 61 |
miR-605 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-605 | miRNA Mature ID | miR-605-5p | ||
miRNA Sequence |
UAAAUCCCAUGGUGCCUUCUCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 62 |
miR-616 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-616 | miRNA Mature ID | miR-616-5p | ||
miRNA Sequence |
ACUCAAAACCCUUCAGUGACUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 63 |
miR-6727 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6727 | miRNA Mature ID | miR-6727-3p | ||
miRNA Sequence |
UCCUGCCACCUCCUCCGCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 64 |
miR-6736 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6736 | miRNA Mature ID | miR-6736-3p | ||
miRNA Sequence |
UCAGCUCCUCUCUACCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 65 |
miR-6747 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6747 | miRNA Mature ID | miR-6747-3p | ||
miRNA Sequence |
UCCUGCCUUCCUCUGCACCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 66 |
miR-6787 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6787 | miRNA Mature ID | miR-6787-3p | ||
miRNA Sequence |
UCUCAGCUGCUGCCCUCUCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 67 |
miR-6835 directly targets SLC38A9 | [ 17 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6835 | miRNA Mature ID | miR-6835-3p | ||
miRNA Sequence |
AAAAGCACUUUUCUGUCUCCCAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 68 |
miR-6875 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-6875 | miRNA Mature ID | miR-6875-3p | ||
miRNA Sequence |
AUUCUUCCUGCCCUGGCUCCAU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 69 |
miR-6890 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-6890 | miRNA Mature ID | miR-6890-3p | ||
miRNA Sequence |
CCACUGCCUAUGCCCCACAG | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 70 |
miR-764 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-764 | miRNA Mature ID | miR-764 | ||
miRNA Sequence |
GCAGGUGCUCACUUGUCCUCCU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
Epigenetic Phenomenon 71 |
miR-8063 directly targets SLC38A9 | [ 15 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-8063 | miRNA Mature ID | miR-8063 | ||
miRNA Sequence |
UCAAAAUCAGGAGUCGGGGCUU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
Epigenetic Phenomenon 72 |
miR-8086 directly targets SLC38A9 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | PAR-CLIP | ||
miRNA Stemloop ID |
miR-8086 | miRNA Mature ID | miR-8086 | ||
miRNA Sequence |
UGCUAGUCUGGACUGAUAUGGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Human embryonic kidney 293 cells (HEK293) | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.